Company intelligence / Profile preview

Or-Genix Therapeutics

Worcester, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Or-Genix has developed first-in-class topical bioactivators that mimic estrogen and block androgen receptors, with rapid local onset and degradation for zero systemic exposure; studies suggest promising efficacy in addressing menopausal skin, scalp, and mucosal disorders, though no clinical trial data are yet published[1][5].

Therapeutic areas: EndocrinologyWomen's HealthDermatology
Modalities: Small moleculeSynthetic estrogen mimicsTopical biologics
Industry: Biotech

Partnerships

Turret Capital Management (strategic investor/partner)

Beyond the preview

Go deeper on Or-Genix Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Or-Genix Therapeutics.

Explore the full profile